Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
about
The endocannabinoid system as an emerging target of pharmacotherapyLipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assayThe cannabinoid acids, analogs and endogenous counterpartsInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Functional role of cannabinoid receptors in urinary bladder.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideIn vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist.Arthritis and pain. Future targets to control osteoarthritis painAM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats.Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats.Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.Cannabinoids:their role in pain and palliation.Cannabinoids, endocannabinoids, and related analogs in inflammationEmerging strategies for exploiting cannabinoid receptor agonists as medicines.Cannabinoids in the management of difficult to treat painCurrent evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.Ajulemic acid: potential treatment for chronic inflammation.
P2860
Q24648473-BEFB72AF-13BD-420B-A274-EEE84E0578F8Q24654730-D24B3B3F-8D00-4F7A-B4F3-CC1202D73D2EQ27009735-B8EBAC6E-8AF7-40B9-ADDB-8903D3272CD6Q28298445-CCAC5252-2E9B-4A9B-91E3-04B63D954A77Q33884859-2D18D346-2CF3-43B4-8D5F-526508E92FE2Q34019573-816F04CC-BC63-479E-8D95-8E4C1951E135Q34292559-3853B9DC-0FB0-4297-9FBA-658E48BDFBEAQ34636446-15D0802F-056D-40F5-8C2D-50AB02D08565Q35484505-D31DEAD8-E75B-41F2-A8E4-2EBA047B5640Q35656543-E20B46F5-3DB9-45FE-9E0F-728F74D11B51Q36015427-496C11D2-EB28-4DB8-B415-77DE05458A17Q36992061-AEDB4855-AE8E-4919-BDC9-DDCA0688FE64Q36997712-A2E895A7-C64C-473D-B448-3CA3FB00955BQ37010970-1467553E-C457-4C60-9B96-FC5336413DAFQ37149113-F15664A6-82F8-4703-AB0C-0ACDEE84A215Q37230665-951A5717-AE17-4497-BCE3-EC7E51463AFBQ41687142-EF609B37-85C7-4D26-B20D-D24E67A20DA4Q47958585-FC06ADA3-6D43-45D7-85B5-3B2140953088Q52594380-3F05F7EC-F5BF-44A6-9621-455629E39A31
P2860
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antihyperalgesic properties of ...... matory pain states in the rat.
@en
type
label
Antihyperalgesic properties of ...... matory pain states in the rat.
@en
prefLabel
Antihyperalgesic properties of ...... matory pain states in the rat.
@en
P2093
P921
P1433
P1476
Antihyperalgesic properties of ...... mmatory pain states in the rat
@en
P2093
Alex Groarke
Alice Chen
Alyson Fox
Christopher Brain
Marcus Peacock
Mohammed Yaqoob
Yvonne Loong
P304
P356
10.1016/J.PAIN.2005.03.037
P407
P577
2005-07-01T00:00:00Z